Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daphne Taylor currently holds 638 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daphne Taylor has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Daphne Taylor's most recent insider trade was on Aug 6, 2026, when they sold 638 shares at $0.00 per share.
Daphne Taylor serves as Executive at Aptevo Therapeutics Inc. (APVO). They have executed 13 insider transactions totaling $0 over their tenure at the company.
Daphne Taylor holds the position of Executive at Aptevo Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Daphne Taylor has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Daphne Taylor was on Aug 6, 2026, when they sold $0 worth of APVO shares. This transaction involved 638 shares at N/A per share.
Daphne Taylor currently owns 638 shares of Aptevo Therapeutics Inc. (APVO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daphne Taylor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daphne Taylor has 13 Form 4 filings on record as an insider at Aptevo Therapeutics Inc..
Set alerts for Daphne Taylor and 40,000+ other insiders.